Zydus Lifesciences Completes Acquisition of Sterling Biotech API Business
Zydus Lifesciences has completed the acquisition of the Active Pharmaceutical Ingredients (API) business of Sterling Biotech. This strategic move expands Zydus's capabilities and product portfolio in the pharmaceutical sector, enhancing its position in the API market.
HDFC Sky·




